Routine: BDMPD16

Package	Total	Call Graph
Diabetes Registry	2	($$ACAR,$$MET,$$SULF,$$TROG)^BDMDD12 $$REFUSAL^BDMPD17
Patient Care Component Reports	1	$$START1^APCLDF

Package	Total	Caller Graph
Diabetes Registry	2	BDMPD10 BDMPD15

Entry Points

Name	Comments	DBIA/ICR reference
LIPID(P,BDATE,EDATE)	;EP
THERAPY(P,BD,EDATE)	;EP - therapy code for epi
ASPIRIN(P,BDATE,EDATE)	;EP

External References

Name	Field # of Occurrence
$$START1^APCLDF	ASPIRIN+3, ASPIRIN+5, LIPID+2, LIPID+5
$$ACAR^BDMDD12	THERAPY+8
$$MET^BDMDD12	THERAPY+6
$$SULF^BDMDD12	THERAPY+4
$$TROG^BDMDD12	THERAPY+10
$$REFUSAL^BDMPD17	ASPIRIN+14, ASPIRIN+19, LIPID+14, LIPID+19

Global Variables Directly Accessed

Name	Line Occurrences (* Changed, ! Killed)
^ATXAX - [#9002226]	ASPIRIN+14, ASPIRIN+19, LIPID+14, LIPID+19
^ATXAX("B"	ASPIRIN+12, ASPIRIN+17, LIPID+12, LIPID+17

Local Variables

Legend:

>>	Not killed explicitly
*	Changed
!	Killed
~	Newed

Name	Field # of Occurrence
%DT	THERAPY+2~
A	ASPIRIN+1~, ASPIRIN+2, ASPIRIN+4, ASPIRIN+7, ASPIRIN+8
>> B	ASPIRIN+2*
BD	THERAPY~, THERAPY+4, THERAPY+6, THERAPY+8, THERAPY+10
BDATE	ASPIRIN~, ASPIRIN+3, ASPIRIN+5, ASPIRIN+14, ASPIRIN+19, LIPID~, LIPID+2, LIPID+5, LIPID+14, LIPID+19
BDM	ASPIRIN+1~, ASPIRIN+5!, LIPID+1~, LIPID+4!
BDM(1	ASPIRIN+4, ASPIRIN+6, LIPID+3, LIPID+6
E	ASPIRIN+1~, ASPIRIN+3, ASPIRIN+5, LIPID+1~, LIPID+2, LIPID+5
EDATE	ASPIRIN~, ASPIRIN+3, ASPIRIN+5, ASPIRIN+14, ASPIRIN+19, LIPID~, LIPID+2, LIPID+5, LIPID+14, LIPID+19 , THERAPY~, THERAPY+4, THERAPY+6, THERAPY+8, THERAPY+10
G	ASPIRIN+1~, ASPIRIN+2, ASPIRIN+11, ASPIRIN+14, ASPIRIN+15, ASPIRIN+16, ASPIRIN+19, ASPIRIN+20, ASPIRIN+21, LIPID+1~ , LIPID+2, LIPID+11, LIPID+14, LIPID+15, LIPID+16, LIPID+19, LIPID+20, LIPID+21
N	ASPIRIN+1~, ASPIRIN+2, ASPIRIN+6, ASPIRIN+7, ASPIRIN+9
O	LIPID+1~, LIPID+2, LIPID+3, LIPID+7, LIPID+9
P	ASPIRIN~, ASPIRIN+3, ASPIRIN+5, ASPIRIN+14, ASPIRIN+19, LIPID~, LIPID+2, LIPID+5, LIPID+14, LIPID+19 , THERAPY~, THERAPY+1, THERAPY+4, THERAPY+6, THERAPY+8, THERAPY+10
S	LIPID+1~, LIPID+2, LIPID+6, LIPID+7, LIPID+8
STR	THERAPY+2~, THERAPY+3, THERAPY+5, THERAPY+7, THERAPY+9, THERAPY+11*, THERAPY+12
T	ASPIRIN+12~, ASPIRIN+13, ASPIRIN+14, ASPIRIN+17~, ASPIRIN+18, ASPIRIN+19, LIPID+12~, LIPID+13, LIPID+14, LIPID+17~ , LIPID+18, LIPID+19
TNAME	THERAPY+2~, THERAPY+3*
U	ASPIRIN+14, ASPIRIN+15, ASPIRIN+19, ASPIRIN+20, LIPID+14, LIPID+15, LIPID+19, LIPID+20
X	ASPIRIN+1~, ASPIRIN+3, ASPIRIN+5, ASPIRIN+14, ASPIRIN+19, LIPID+1~, LIPID+2, LIPID+5, LIPID+14, LIPID+19 , THERAPY+2~, THERAPY+4, THERAPY+5, THERAPY+6, THERAPY+7, THERAPY+8, THERAPY+9, THERAPY+10, THERAPY+11
Y	THERAPY+2~

Customize PDF page

Package: Diabetes Registry

Routine: BDMPD16

Information

Source Information

Call Graph

Call Graph Total: 3

Caller Graph

Caller Graph Total: 2

Entry Points

External References

Global Variables Directly Accessed

Local Variables

Legend: